Europe Metabotropic Glutamate Receptor 5 Market was valued at USD 0.5 Billion in 2022 and is projected to reach USD 1.0 Billion by 2030, growing at a CAGR of 9.0% from 2024 to 2030.
The Europe Metabotropic Glutamate Receptor 5 (mGluR5) market is experiencing significant growth, driven by increasing research into neurological diseases and the demand for targeted therapies. mGluR5 plays a pivotal role in synaptic plasticity and is implicated in a wide range of conditions, including Alzheimer's disease, Parkinson's disease, and various psychiatric disorders. The industrial need for these receptors is rising as researchers and pharmaceutical companies focus on developing novel treatments for these debilitating diseases.
In Europe, the demand for mGluR5 research and therapeutic applications is intensifying, particularly due to the rising prevalence of neurological conditions. mGluR5 is involved in cognitive processes, and abnormalities in its function are linked to a variety of psychiatric and neurological disorders. This has led to a surge in clinical trials targeting mGluR5 to find effective treatments for conditions like schizophrenia and depression.
The industrial requirement for mGluR5-based therapies is driven by the increasing number of clinical research studies, particularly in the pharmaceutical and biotech sectors. The market is benefiting from both private and public investments aimed at discovering novel drugs that modulate the receptor's activity. Additionally, advancements in biotechnology are allowing for more precise targeting of mGluR5, which is fueling demand in the medical and pharmaceutical industries.
Pharmaceutical companies are also focusing on the development of allosteric modulators that interact with mGluR5, which can lead to more effective treatments with fewer side effects compared to traditional therapies. This growing interest in the functional modulation of mGluR5 is not only enhancing therapeutic options but also driving market expansion in the European region.
The Europe Metabotropic Glutamate Receptor 5 market is witnessing a robust demand from the healthcare industry, as mGluR5-related research and therapies show immense potential for addressing a range of neurological and psychiatric disorders. As the market continues to evolve, the industrial need for innovative treatments targeting mGluR5 will likely increase, providing valuable opportunities for both researchers and pharmaceutical companies alike.
Get an In-Depth Research Analysis of the Europe Metabotropic Glutamate Receptor 5 Market Size And Forecast [2025-2032]
Â
Addex Therapeutics Ltd
Aevi Genomic Medicine Inc Bristol-Myers Squibb Company
Eisai Co Ltd
Eli Lilly and Company
Heptares Therapeutics Ltd
Johnson & Johnson
Merz Pharma GmbH & Co KgaA
Novartis AG
Richter Gedeon Nyrt
Sumitomo Dainippon Pharma Co Ltd
Toray Industries Inc
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe Metabotropic Glutamate Receptor 5 Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe Metabotropic Glutamate Receptor 5 Market
Cognitive Disorders
Neurodegenerative Diseases
Psychiatric Disorders
Epilepsy
Pharmaceutical Companies
Research Institutions
Hospitals and Clinics
Contract Research Organizations
Agonists
Antagonists
Allosteric Modulators
Oral
Intravenous
Topical
Preclinical Studies
Clinical Trials
Basic Research
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Metabotropic Glutamate Receptor 5 Market Research Analysis
1. Introduction of the Europe Metabotropic Glutamate Receptor 5 Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe Metabotropic Glutamate Receptor 5 Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe Metabotropic Glutamate Receptor 5 Market, By Type
6. Europe Metabotropic Glutamate Receptor 5 Market, By Application
7. Europe Metabotropic Glutamate Receptor 5 Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Europe Metabotropic Glutamate Receptor 5 Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Europe Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/